{"id":8687,"date":"2024-10-08T09:31:36","date_gmt":"2024-10-08T13:31:36","guid":{"rendered":"https:\/\/groupedevonian.com\/devonian-annonce-loctroi-doptions-dachat-dactions\/"},"modified":"2024-10-10T17:49:26","modified_gmt":"2024-10-10T21:49:26","slug":"devonian-annonce-loctroi-doptions-dachat-dactions","status":"publish","type":"post","link":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-loctroi-doptions-dachat-dactions\/","title":{"rendered":"DEVONIAN ANNONCE L\u2019OCTROI D\u2019OPTIONS D\u2019ACHAT D\u2019ACTIONS"},"content":{"rendered":"

COMMUNIQU\u00c9 DE PRESSE
\nPour diffusion imm\u00e9diate<\/em><\/strong><\/p>\n

DEVONIAN ANNONCE L’OCTROI D’OPTIONS D’ACHAT D’ACTIONS<\/h1>\n

QU\u00c9BEC,<\/strong> 8 octobre 2024<\/strong> \u2013 Groupe Sant\u00e9 Devonian Inc. (“Devonian<\/strong>” ou la “Soci\u00e9t\u00e9<\/strong>”) (TSXv: GSD<\/strong>), une soci\u00e9t\u00e9 biopharmaceutique botanique en stade avanc\u00e9 de d\u00e9veloppement ax\u00e9e sur l’\u00e9laboration d’un portefeuille unique de m\u00e9dicaments d’ordonnance et de produits cosm\u00e9ceutiques d’origine botanique, annonce que le conseil d’administration a approuv\u00e9 l’octroi d’options d’achat d’actions de la Soci\u00e9t\u00e9 (les \u00ab Options<\/strong> \u00bb), \u00e0 un prix d’exercice de 0,16 $ pour une p\u00e9riode de 10 ans \u00e0 compter de la date d’attribution et conform\u00e9ment aux termes et modalit\u00e9s du r\u00e9gime d’options d’achat d’actions de la Soci\u00e9t\u00e9. Un total de 3 298 611 Options a \u00e9t\u00e9 attribu\u00e9 aux dirigeants de la Soci\u00e9t\u00e9. Ces Options sont exer\u00e7ables \u00e0 la date d’attribution.<\/p>\n

Au sujet de Devonian<\/strong><\/p>\n

Devonian est une soci\u00e9t\u00e9 biopharmaceutique botanique en stade avanc\u00e9 de d\u00e9veloppement qui emploie une strat\u00e9gie novatrice ciblant des besoins m\u00e9dicaux non combl\u00e9s. La principale strat\u00e9gie de Devonian est de d\u00e9velopper des m\u00e9dicaments d’ordonnance d’origine botanique pour le traitement des maladies inflammatoires auto-immunes incluant, mais sans s’y limiter, la colite ulc\u00e9reuse et la dermatite atopique. Fond\u00e9 sur une assise de 15 ann\u00e9es de recherche, l’objectif de Devonian est \u00e9galement appuy\u00e9 par les directives r\u00e9glementaires de la U.S.<\/em> Food and Drug Administration (FDA)<\/em>, l’agence am\u00e9ricaine des produits alimentaires et m\u00e9dicamenteux, favorisant un processus de d\u00e9veloppement de produits m\u00e9dicamenteux botaniques d’ordonnance plus efficient que celui des m\u00e9dicaments d’ordonnance classique.<\/p>\n

Devonian est \u00e9galement impliqu\u00e9e dans le d\u00e9veloppement de produits cosm\u00e9ceutiques de grande valeur en s’appuyant sur la m\u00eame approche exclusive que celle utilis\u00e9e avec leurs offres pharmaceutiques. Groupe Sant\u00e9 Devonian Inc. a \u00e9t\u00e9 constitu\u00e9e en 2015 et a son si\u00e8ge social au Qu\u00e9bec, au Canada, o\u00f9 elle poss\u00e8de une installation d’extraction \u00e0 la pointe de la technologie avec une tra\u00e7abilit\u00e9 compl\u00e8te \u00ab de la graine \u00e0 la pilule \u00bb. Acquise en 2018, Altius Healthcare Inc., sa filiale de commercialisation, offre des opportunit\u00e9s de diversification et de potentiel de croissance suppl\u00e9mentaires. <\/p>\n

Devonian est cot\u00e9e \u00e0 la Bourse de croissance TSX (TSXv: GSD<\/strong>) ainsi que sur la bourse de croissance OTCQB (OTCQB: DVBHGF<\/strong>).<\/p>\n

Pour plus de d\u00e9tails, visitez le www.groupedevonian.com<\/a> <\/p>\n

\u00c9nonc\u00e9s prospectifs<\/strong><\/p>\n

Le pr\u00e9sent communiqu\u00e9 renferme des \u00e9nonc\u00e9s prospectifs sur les objectifs, les strat\u00e9gies et les activit\u00e9s de Devonian. Ces \u00e9nonc\u00e9s prospectifs sont assujettis \u00e0 certains risques et incertitudes. Ces \u00e9nonc\u00e9s sont de nature \u00ab\u2009prospective\u2009\u00bb puisqu’ils sont fond\u00e9s sur nos attentes pr\u00e9sentes \u00e0 l’\u00e9gard des march\u00e9s dans lesquels nous exer\u00e7ons nos activit\u00e9s et sur diverses estimations et hypoth\u00e8ses. Les \u00e9v\u00e9nements ou les r\u00e9sultats r\u00e9els sont susceptibles de diff\u00e9rer consid\u00e9rablement de ceux pr\u00e9vus dans le cadre des \u00e9nonc\u00e9s prospectifs si des risques connus ou inconnus affectent nos activit\u00e9s ou si nos estimations ou nos hypoth\u00e8ses s’av\u00e8rent inexactes. Ces risques, estimations et hypoth\u00e8ses incluent, mais sans s’y limiter, la capacit\u00e9 de Devonian d’assurer le d\u00e9veloppement, la fabrication et la commercialisation de produits pharmaceutiques et dermo-cosm\u00e9tiques \u00e0 valeur ajout\u00e9e, la disponibilit\u00e9 de ressources financi\u00e8res pour mener \u00e0 bien des projets de recherche et d\u00e9veloppement, le succ\u00e8s et la dur\u00e9e d’\u00e9tudes cliniques, la capacit\u00e9 de Devonian de se pr\u00e9valoir des occasions d’affaires dans l’industrie pharmaceutique et dermo-cosm\u00e9tique, les incertitudes li\u00e9es au processus de r\u00e9glementation et tout changement du contexte \u00e9conomique. Vous trouverez une analyse plus exhaustive des risques qui pourraient faire en sorte que les \u00e9v\u00e9nements ou r\u00e9sultats r\u00e9els diff\u00e8rent de nos attentes pr\u00e9sentes de fa\u00e7on importante dans le prospectus en date du 21 avril 2017, sous la rubrique \u00ab\u2009Facteurs de risque\u2009\u00bb. Par cons\u00e9quent, nous ne pouvons garantir la r\u00e9alisation des \u00e9nonc\u00e9s prospectifs. Par ailleurs, nous ne nous engageons aucunement \u00e0 mettre \u00e0 jour ces \u00e9nonc\u00e9s prospectifs, m\u00eame si de nouveaux renseignements devenaient disponibles, \u00e0 la suite d’\u00e9v\u00e9nements futurs ou pour toute autre raison, \u00e0 moins d’y \u00eatre tenus en vertu des lois et r\u00e8glements applicables aux valeurs mobili\u00e8res.<\/p>\n

La Bourse de croissance TSX et son fournisseur de services de r\u00e9glementation (au sens attribu\u00e9 \u00e0 ce terme dans les politiques de la Bourse de croissance TSX) n’assument aucune responsabilit\u00e9 quant \u00e0 la pertinence ou \u00e0 l’exactitude du pr\u00e9sent communiqu\u00e9.<\/em><\/p>\n

Contact : <\/p>\n

Luc Gr\u00e9goire<\/strong>
\n Pr\u00e9sident et chef de la direction
\n Groupe Sant\u00e9 Devonian inc.
\n T\u00e9l\u00e9phone : 1 (450) 979-2916
\n Courriel: investors@groupedevonian.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

COMMUNIQU\u00c9 DE PRESSE Pour diffusion imm\u00e9diate DEVONIAN ANNONCE L’OCTROI D’OPTIONS D’ACHAT D’ACTIONS QU\u00c9BEC, 8 octobre 2024 \u2013 Groupe Sant\u00e9 Devonian Inc. (“Devonian” ou la “Soci\u00e9t\u00e9”) (TSXv: GSD), une soci\u00e9t\u00e9 biopharmaceutique botanique en stade avanc\u00e9 de d\u00e9veloppement ax\u00e9e sur l’\u00e9laboration d’un portefeuille unique de m\u00e9dicaments d’ordonnance et de produits cosm\u00e9ceutiques d’origine botanique, annonce que le conseil […]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[79,35],"tags":[],"class_list":["post-8687","post","type-post","status-publish","format-standard","hentry","category-2024-fr","category-communiques-de-presse"],"yoast_head":"\nDEVONIAN ANNONCE L\u2019OCTROI D\u2019OPTIONS D\u2019ACHAT D\u2019ACTIONS - DEVONIAN HEALTH GROUP INC.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/groupedevonian.com\/fr\/devonian-annonce-loctroi-doptions-dachat-dactions\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DEVONIAN ANNONCE L\u2019OCTROI D\u2019OPTIONS D\u2019ACHAT D\u2019ACTIONS - DEVONIAN HEALTH GROUP INC.\" \/>\n<meta property=\"og:description\" content=\"COMMUNIQU\u00c9 DE PRESSE Pour diffusion imm\u00e9diate DEVONIAN ANNONCE L’OCTROI D’OPTIONS D’ACHAT D’ACTIONS QU\u00c9BEC, 8 octobre 2024 \u2013 Groupe Sant\u00e9 Devonian Inc. (“Devonian” ou la “Soci\u00e9t\u00e9”) (TSXv: GSD), une soci\u00e9t\u00e9 biopharmaceutique botanique en stade avanc\u00e9 de d\u00e9veloppement ax\u00e9e sur l’\u00e9laboration d’un portefeuille unique de m\u00e9dicaments d’ordonnance et de produits cosm\u00e9ceutiques d’origine botanique, annonce que le conseil […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/groupedevonian.com\/fr\/devonian-annonce-loctroi-doptions-dachat-dactions\/\" \/>\n<meta property=\"og:site_name\" content=\"DEVONIAN HEALTH GROUP INC.\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-08T13:31:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-10T21:49:26+00:00\" \/>\n<meta name=\"author\" content=\"acxdev\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"acxdev\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/devonian-annonce-loctroi-doptions-dachat-dactions\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/devonian-annonce-loctroi-doptions-dachat-dactions\\\/\"},\"author\":{\"name\":\"acxdev\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#\\\/schema\\\/person\\\/ff9b4cc2d46ac4fb34e4f4641825f159\"},\"headline\":\"DEVONIAN ANNONCE L\u2019OCTROI D\u2019OPTIONS D\u2019ACHAT D\u2019ACTIONS\",\"datePublished\":\"2024-10-08T13:31:36+00:00\",\"dateModified\":\"2024-10-10T21:49:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/devonian-annonce-loctroi-doptions-dachat-dactions\\\/\"},\"wordCount\":861,\"publisher\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#organization\"},\"articleSection\":[\"2024\",\"Communiqu\u00e9s de presse\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/devonian-annonce-loctroi-doptions-dachat-dactions\\\/\",\"url\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/devonian-annonce-loctroi-doptions-dachat-dactions\\\/\",\"name\":\"DEVONIAN ANNONCE L\u2019OCTROI D\u2019OPTIONS D\u2019ACHAT D\u2019ACTIONS - DEVONIAN HEALTH GROUP INC.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#website\"},\"datePublished\":\"2024-10-08T13:31:36+00:00\",\"dateModified\":\"2024-10-10T21:49:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/devonian-annonce-loctroi-doptions-dachat-dactions\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/devonian-annonce-loctroi-doptions-dachat-dactions\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/devonian-annonce-loctroi-doptions-dachat-dactions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DEVONIAN ANNONCE L\u2019OCTROI D\u2019OPTIONS D\u2019ACHAT D\u2019ACTIONS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/\",\"name\":\"DEVONIAN HEALTH GROUP INC.\",\"description\":\"Botanical pharmaceutical corporation\",\"publisher\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#organization\",\"name\":\"Groupe Sant\u00e9 Devonian inc.\",\"alternateName\":\"Groupe Sant\u00e9 Devonian inc.\",\"url\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/groupedevonian.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/logo-devonian-2x.png\",\"contentUrl\":\"https:\\\/\\\/groupedevonian.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/logo-devonian-2x.png\",\"width\":309,\"height\":183,\"caption\":\"Groupe Sant\u00e9 Devonian inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#\\\/schema\\\/person\\\/ff9b4cc2d46ac4fb34e4f4641825f159\",\"name\":\"acxdev\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g\",\"caption\":\"acxdev\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DEVONIAN ANNONCE L\u2019OCTROI D\u2019OPTIONS D\u2019ACHAT D\u2019ACTIONS - DEVONIAN HEALTH GROUP INC.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-loctroi-doptions-dachat-dactions\/","og_locale":"fr_FR","og_type":"article","og_title":"DEVONIAN ANNONCE L\u2019OCTROI D\u2019OPTIONS D\u2019ACHAT D\u2019ACTIONS - DEVONIAN HEALTH GROUP INC.","og_description":"COMMUNIQU\u00c9 DE PRESSE Pour diffusion imm\u00e9diate DEVONIAN ANNONCE L’OCTROI D’OPTIONS D’ACHAT D’ACTIONS QU\u00c9BEC, 8 octobre 2024 \u2013 Groupe Sant\u00e9 Devonian Inc. (“Devonian” ou la “Soci\u00e9t\u00e9”) (TSXv: GSD), une soci\u00e9t\u00e9 biopharmaceutique botanique en stade avanc\u00e9 de d\u00e9veloppement ax\u00e9e sur l’\u00e9laboration d’un portefeuille unique de m\u00e9dicaments d’ordonnance et de produits cosm\u00e9ceutiques d’origine botanique, annonce que le conseil […]","og_url":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-loctroi-doptions-dachat-dactions\/","og_site_name":"DEVONIAN HEALTH GROUP INC.","article_published_time":"2024-10-08T13:31:36+00:00","article_modified_time":"2024-10-10T21:49:26+00:00","author":"acxdev","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"acxdev","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-loctroi-doptions-dachat-dactions\/#article","isPartOf":{"@id":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-loctroi-doptions-dachat-dactions\/"},"author":{"name":"acxdev","@id":"https:\/\/groupedevonian.com\/fr\/#\/schema\/person\/ff9b4cc2d46ac4fb34e4f4641825f159"},"headline":"DEVONIAN ANNONCE L\u2019OCTROI D\u2019OPTIONS D\u2019ACHAT D\u2019ACTIONS","datePublished":"2024-10-08T13:31:36+00:00","dateModified":"2024-10-10T21:49:26+00:00","mainEntityOfPage":{"@id":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-loctroi-doptions-dachat-dactions\/"},"wordCount":861,"publisher":{"@id":"https:\/\/groupedevonian.com\/fr\/#organization"},"articleSection":["2024","Communiqu\u00e9s de presse"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-loctroi-doptions-dachat-dactions\/","url":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-loctroi-doptions-dachat-dactions\/","name":"DEVONIAN ANNONCE L\u2019OCTROI D\u2019OPTIONS D\u2019ACHAT D\u2019ACTIONS - DEVONIAN HEALTH GROUP INC.","isPartOf":{"@id":"https:\/\/groupedevonian.com\/fr\/#website"},"datePublished":"2024-10-08T13:31:36+00:00","dateModified":"2024-10-10T21:49:26+00:00","breadcrumb":{"@id":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-loctroi-doptions-dachat-dactions\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/groupedevonian.com\/fr\/devonian-annonce-loctroi-doptions-dachat-dactions\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-loctroi-doptions-dachat-dactions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/groupedevonian.com\/fr\/"},{"@type":"ListItem","position":2,"name":"DEVONIAN ANNONCE L\u2019OCTROI D\u2019OPTIONS D\u2019ACHAT D\u2019ACTIONS"}]},{"@type":"WebSite","@id":"https:\/\/groupedevonian.com\/fr\/#website","url":"https:\/\/groupedevonian.com\/fr\/","name":"DEVONIAN HEALTH GROUP INC.","description":"Botanical pharmaceutical corporation","publisher":{"@id":"https:\/\/groupedevonian.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/groupedevonian.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/groupedevonian.com\/fr\/#organization","name":"Groupe Sant\u00e9 Devonian inc.","alternateName":"Groupe Sant\u00e9 Devonian inc.","url":"https:\/\/groupedevonian.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/groupedevonian.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/groupedevonian.com\/wp-content\/uploads\/2022\/05\/logo-devonian-2x.png","contentUrl":"https:\/\/groupedevonian.com\/wp-content\/uploads\/2022\/05\/logo-devonian-2x.png","width":309,"height":183,"caption":"Groupe Sant\u00e9 Devonian inc."},"image":{"@id":"https:\/\/groupedevonian.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/groupedevonian.com\/fr\/#\/schema\/person\/ff9b4cc2d46ac4fb34e4f4641825f159","name":"acxdev","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g","caption":"acxdev"}}]}},"_links":{"self":[{"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/posts\/8687","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/comments?post=8687"}],"version-history":[{"count":2,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/posts\/8687\/revisions"}],"predecessor-version":[{"id":8689,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/posts\/8687\/revisions\/8689"}],"wp:attachment":[{"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/media?parent=8687"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/categories?post=8687"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/tags?post=8687"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}